Ella Ittner

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Non-parametric differential methylation analysis characterizes histotype-specific promoter regions in epithelial ovarian cancer.

Non-parametric differential methylation analysis characterizes histotype-specific promoter regions in epithelial ovarian cancer.

Journal: Epigenetics
Published: September 02, 2026

The phosphoproteome of ovarian carcinoma delineates signaling signatures and potentially druggable targets across histotype stages.

The phosphoproteome of ovarian carcinoma delineates signaling signatures and potentially druggable targets across histotype stages.

Journal: NPJ precision oncology
Published: January 15, 2026

Proteomic analysis of ovarian carcinoma reveals diagnostic and prognostic biomarkers with histotype- and stage-specificity.

Proteomic analysis of ovarian carcinoma reveals diagnostic and prognostic biomarkers with histotype- and stage-specificity.

Journal: Journal of ovarian research
Published: September 08, 2025

LMTK3 as a spatially regulated and stage-dependent biomarker in epithelial ovarian tumorigenesis.

LMTK3 as a spatially regulated and stage-dependent biomarker in epithelial ovarian tumorigenesis.

Journal: Molecular therapy. Oncology
Published: August 27, 2025

Diagnostic and prognostic biomarkers associated with histotype in advanced epithelial ovarian cancer.

Diagnostic and prognostic biomarkers associated with histotype in advanced epithelial ovarian cancer.

Journal: Scientific reports
Published: May 28, 2025

Unveiling histotype-specific biomarkers in ovarian carcinoma using proteomics.

Unveiling histotype-specific biomarkers in ovarian carcinoma using proteomics.

Journal: Molecular therapy. Oncology
Published: May 13, 2025

Predicting immune responsiveness in ER-positive breast cancer for personalized therapy: a population-based study.

Predicting immune responsiveness in ER-positive breast cancer for personalized therapy: a population-based study.

Journal: NPJ precision oncology
Published: March 14, 2025

Integrative analysis of epigenetic and transcriptional interrelations identifies histotype-specific biomarkers in early-stage ovarian carcinoma.

Integrative analysis of epigenetic and transcriptional interrelations identifies histotype-specific biomarkers in early-stage ovarian carcinoma.

Journal: Journal of ovarian research
Published: March 03, 2025

Lemur tail kinase 3 serves as a predictor of patient outcomes and a target for the treatment of ovarian cancer.

Lemur tail kinase 3 serves as a predictor of patient outcomes and a target for the treatment of ovarian cancer.

Journal: Molecular therapy. Oncology
Published: December 14, 2023

Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer.

Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer.

Journal: Cell death discovery
Published: June 04, 2023

SoxD transcription factor deficiency in Schwann cells delays myelination in the developing peripheral nervous system.

SoxD transcription factor deficiency in Schwann cells delays myelination in the developing peripheral nervous system.

Journal: Scientific reports
Published: May 16, 2021

Dietary Fiber and the Hippocampal Neurogenic Niche in a Model of Pelvic Radiotherapy.

Dietary Fiber and the Hippocampal Neurogenic Niche in a Model of Pelvic Radiotherapy.

Journal: Neuroscience
Published: January 15, 2021
Showing 1-12 of 12

Last Updated: 09/26/2026